Gordon B. Mills MD, PhD

Dr. Mills is professor at The University of Texas MD Anderson Cancer Center with joint appointments in Systems Biology, Breast Medical Oncology, and Immunology; serves as chair of the Department of Systems Biology; and holds the Wiess Distinguished University Chair in Cancer Medicine. He is director of the Kleberg Center for Molecular Markers, and codirector of the Sheikh Zayed bin Sultan Al Nahyan Institute for Personalized Cancer Therapy and the Women’s Cancer Moonshot. Dr. Mills currently serves as principal investigator or project investigator on many national peer-reviewed grants including NIH/NCI SPOREs, Stand Up To Cancer, and Komen Foundation grants. He has published more than 700 papers on the molecular analysis of cancer and holds more than 20 patents related to novel technologies and molecular markers. He was recently awarded the Komen Brinker Award for Scientific Excellence, the Stand Up To Cancer Laura Ziskin Prize for mentoring, and the Finneran Family Prize in Translational Research.